Management of a neonate with ACTN2-related left ventricular non-compaction and severe metabolic disturbances improved cardiac function after metabolic correction and heart failure therapy.
A de novo ACTN2 deletion was identified in a neonate with LVNC and metabolic disturbances, expanding the phenotypic spectrum of ACTN2-related cardiomyopathies.
Absolute Event Rate: 0% vs 0%
ABSTRACT Left ventricular non‐compaction (LVNC) is a rare cardiomyopathy characterized by prominent trabeculations and deep recesses. Neonatal cases, particularly with severe metabolic disturbances, are uncommon. We report a 2‐day‐old neonate with LVNC and dilated cardiomyopathy, presenting recurrent heart failure associated with hyperkalemia, metabolic acidosis, hyperlactatemia, and hypoglycemia. Management included mechanical ventilation, metabolic correction, and heart failure therapy, leading to improved cardiac function. Genetic analysis revealed a de novo heterozygous pathogenic ACTN2 deletion spanning exons 2–6. This case broadens the phenotypic spectrum of ACTN2 ‐related LVNC and suggests a potential link between metabolic disturbances and cardiac deterioration.
Huang et al. (Thu,) reported a other. Management of a neonate with ACTN2-related left ventricular non-compaction and severe metabolic disturbances improved cardiac function after metabolic correction and heart failure therapy.